More answers like this
Grok 4.5Oct 27, 2026x-ai/grok-4.5-20260708

Is the US prepared to deal with another pandemic or widespread health crisis?

No

No, the US is not fully prepared for another pandemic or major widespread health crisis, though it has made notable improvements in some technical and logistical areas since COVID-19 while facing persistent and, in some cases, worsened gaps in coordination, workforce, sustained funding, leadership, and public trust. Expert assessments, government reports, and recent analyses consistently highlight vulnerabilities to natural outbreaks, lab accidents, or deliberate biological threats, compounded by emerging risks like AI-enabled pathogen design. Preparedness remains uneven across federal, state, and local levels.[1]

Strengths and Post-COVID Improvements

The US has stronger capabilities in certain domains than before 2020:

•Stockpiles and medical countermeasures (MCMs): The Strategic National Stockpile (SNS) was significantly restocked. By early 2025 reporting, it held far higher quantities of PPE (e.g., ~70 times more N95 respirators, substantially more gloves, gowns, and ventilators) than pre-pandemic levels. Agencies like BARDA (Biomedical Advanced Research and Development Authority) and ASPR (Administration for Strategic Preparedness and Response) continue developing and procuring vaccines, therapeutics, and diagnostics (e.g., for H5N1 bird flu, mpox/Ebola-related assets). Recent contracts and prize competitions support antiviral and manufacturing innovation.[2]
•Surveillance and data systems: Major advances include expanding automated electronic case reporting from fewer than 200 healthcare facilities pre-COVID to over 45,000–48,000 by 2024, plus broader syndromic surveillance and wastewater monitoring. These enable faster detection.[3]
•International Health Regulations (IHR) capacities: The 2024 WHO Joint External Evaluation (JEE, 3rd edition tool incorporating COVID lessons) gave the US high average scores in many technical areas (e.g., biosafety/biosecurity ~100%, national laboratory system ~95%, surveillance ~93%, emergency response operations ~100%, immunization-related ~100% in some metrics). Lower scores appeared in areas like IHR coordination/communication (~60%) and national legislation/policy/financing (~70%). Overarching recommendations focused on better alignment across federal/state/local/tribal/territorial (SLTT) levels, workforce sustainability, and reducing fragmentation.[4]
•Other assets: Health Care Coalitions, Medical Reserve Corps volunteers, some cross-state credentialing (e.g., Nurse Licensure Compact in 41 states), and residual manufacturing/scale-up experience from Operation Warp Speed-style efforts. ASPR continues real-world responses (H5N1 PPE/antivirals, Ebola/mpox support, disaster medical stations). Global investments (pre-recent shifts) and the Pandemic Fund helped partner countries.[5]

The Biden administration’s roadmap, Global Health Security Strategy, and Office of Pandemic Preparedness and Response Policy (OPPR, established 2023) aimed to institutionalize lessons. The Bipartisan Commission on Biodefense’s 2024 National Blueprint acknowledged progress but stressed remaining dangers.[1]

Persistent and Recent Weaknesses

Significant shortfalls remain or have intensified:

•Open recommendations and systemic issues: As of mid-2024, GAO had ~220 open recommendations (out of 428+) from COVID oversight, covering HHS leadership/coordination, supply chain resilience, testing strategies, data sharing, unemployment/UI systems, and more. High-risk areas include emergency leadership and MCM development/manufacturing. Funding shortfalls for PHEMCE (Public Health Emergency Medical Countermeasures Enterprise) were projected in the tens of billions.[6]
•Leadership, coordination, and workforce: Fragmented authorities across agencies persist. Recent changes (2025–2026) include major CDC staffing reductions (reports of ~3,000 people/~25% of staff, including experienced scientists), an understaffed or largely inactive OPPR, NIH/NIAID strategic shifts away from biodefense/emerging infectious disease/pandemic prep research (with some funds redirected toward DoD), gain-of-function research restrictions, and WHO withdrawal. PAHPA (Pandemic and All-Hazards Preparedness Act) authorities have faced lapses or need modernization/reauthorization. Public health workforce shortages and high turnover were already concerns.[7]
•State/local variation and infrastructure: Trust for America’s Health (TFAH) Ready or Not 2026 report placed 20 states in a high-performance tier, 17 + DC in middle, and 13 in low for emergency preparedness indicators (e.g., lab surge plans strong nearly everywhere; nurse compact good; but state public health funding cuts in ≥12 states, low flu vaccination in many areas, uneven paid sick leave, hospital patient safety variation, avoidable mortality disparities, and water system risks). Federal funding/workforce instability risks cascading effects. Climate/weather extremes and compounding threats (severe flu, measles resurgence, H5N1) strain systems.[8]
•Broader risks: Supply chain vulnerabilities (especially domestic manufacturing), antimicrobial resistance (AMR), inequities in access/trust, misinformation/vaccine hesitancy, and dual-use research oversight challenges. AI is accelerating both defensive tools and offensive/design risks for novel pathogens. Bipartisan Commission updates and others call for treating biodefense as a sustained national security priority (akin to a “Manhattan Project” or Apollo-scale effort), better intelligence/attribution, and continuous (not boom-bust) investment. Economic costs of another COVID-scale event would dwarf preparedness spending.[9]
•Expert consensus: Multiple 2025–2026 analyses (Bloomberg, Guardian, STAT, Contagion Live, CSIS, Bulletin of the Atomic Scientists, etc.) conclude the US is less prepared in key human/coordination dimensions than during COVID (itself imperfect, with high US per-capita mortality early on) due to recent erosions, even as some hardware/tech improved. Probability models suggest substantial risk of another severe pandemic in coming decades.[10]

Bottom Line and Path Forward

The US has robust scientific, manufacturing, and logistical foundations and learned hard lessons from COVID-19, mpox, H5N1, and other events—enabling faster detection and some MCM availability than in 2020. However, it is not adequately prepared for a novel high-consequence pathogen or coordinated crisis due to incomplete implementation of lessons, boom-bust funding/politics, workforce attrition, coordination gaps, and eroded trust/international engagement. State-level capacity varies widely, and federal systems face strain.

Sustained bipartisan action is needed: stable multi-year funding for ASPR/BARDA/SNS/CDC core capacities and data modernization; PAHPA reauthorization/modernization; workforce rebuilding; SLTT strengthening; clear White House-level leadership; biosurveillance/AI safeguards; MCM platforms (e.g., rapid vaccines/therapeutics); and addressing equity/trust. Treating pandemics as core national security (not just health) threats, with regular exercises and accountability, would help close gaps. Without this, another crisis risks repeating or exceeding COVID’s toll. Assessments evolve with policy and funding decisions.

Citations (10)

  1. 1biodefensecommission.orgNonprofits and think tanks
    https://biodefensecommission.org/reports/the-national-blueprint-for-biodefense/

    Backs: “Preparedness remains uneven across federal, state, and local levels.”

    evidence, official document, points to no. Claim: US is not fully prepared; experts highlight vulnerabilities to natural, accidental, and deliberate biological threats, with uneven preparedness across levels of government.

  2. 2archives.govGovernment
    https://bidenwhitehouse.archives.gov/briefing-room/statements-releases/2025/01/14/report-the-biden-harris-administration-roadmap-for-pandemic-preparedness-and-response/

    Backs: “Recent contracts and prize competitions support antiviral and manufacturing innovation.”

    statistic, official document, points to yes. Claim: Strategic National Stockpile restocked with far more PPE (e.g., ~70 times more N95s); BARDA and ASPR continue developing countermeasures.

  3. 3cdc.govGovernment
    https://www.cdc.gov/washington/testimony/2024/t20241114.htm

    Backs: “Major advances include expanding automated electronic case reporting from fewer than 200 healthcare facilities pre-COVID to over 45,000–48,000 by 2024, plus broader syndromic surveillance and wastewater monitoring. These enable faster detection.”

    statistic, official document, points to yes. Claim: Electronic case reporting expanded from under 200 facilities pre-COVID to over 45,000 by 2024, enabling faster detection.

  4. 4who.intGovernment
    https://extranet.who.int/sph/jee-united-states-america-conducted-0

    Backs: “Overarching recommendations focused on better alignment across federal/state/local/tribal/territorial (SLTT) levels, workforce sustainability, and reducing fragmentation.”

    statistic, official document, points to yes. Claim: 2024 WHO Joint External Evaluation gave the US high technical scores, with lower scores in coordination and legislation/financing.

  5. 5aspr.govGovernment
    https://www.aspr.gov/

    Backs: “Global investments (pre-recent shifts) and the Pandemic Fund helped partner countries.”

    evidence, home page, points to yes. Claim: Other assets like Health Care Coalitions, Medical Reserve Corps, and ASPR's ongoing real-world responses support preparedness.

  6. 6gao.govGovernment
    https://www.gao.gov/products/gao-24-107175

    Backs: “Funding shortfalls for PHEMCE (Public Health Emergency Medical Countermeasures Enterprise) were projected in the tens of billions.”

    statistic, official document, points to no. Claim: GAO had about 220 open COVID-oversight recommendations as of mid-2024; high-risk areas include emergency leadership and countermeasure development.

  7. 7bloomberg.comNews and mediaquality 0.84
    https://www.bloomberg.com/news/articles/2026-06-11/is-the-us-prepared-for-the-next-pandemic-how-trump-s-policies-weakened-defenses

    Backs: “Public health workforce shortages and high turnover were already concerns.”

    evidence, article, points to no. Claim: Recent CDC staffing cuts, inactive OPPR, NIH shifts, and WHO withdrawal have weakened US pandemic defenses.

  8. 8tfah.orgNonprofits and think tanks
    https://www.tfah.org/report-details/ready-or-not-2026/

    Backs: “Climate/weather extremes and compounding threats (severe flu, measles resurgence, H5N1) strain systems.”

    statistic, official document, points to no. Claim: TFAH Ready or Not 2026 rated 20 states high, 17 plus DC middle, 13 low on preparedness; funding cuts in at least 12 states.

  9. 9biodefensecommission.orgNonprofits and think tanks
    https://biodefensecommission.org/reports/an-update-to-the-apollo-program-for-biodefense-winning-the-race-against-biological-threats/

    Backs: “Economic costs of another COVID-scale event would dwarf preparedness spending.”

    attribution, official document, points to no. Claim: Bipartisan Commission calls for treating biodefense as a sustained national security priority with continuous investment.

  10. 10thebulletin.orgNews and mediaquality 0.82
    https://thebulletin.org/premium/2025-12/the-united-states-isnt-prepared-for-another-pandemic-heres-what-should-happen/

    Backs: “Probability models suggest substantial risk of another severe pandemic in coming decades.”

    attribution, article, points to no. Claim: Multiple 2025-2026 analyses conclude the US is less prepared in human and coordination dimensions than during COVID.